Abstract:Background: Krüppel-like factor 5 (KLF5) is a zinc-finger transcription factor that is highly expressed in the crypt cells of the intestinal epithelia and plays a critical role in regulating proliferation of both normal intestinal epithelial cells and colorectal cancer cells.We previously showed that KLF5 is a critical mediator for intestinal tumorigenesis resulted from either ApcMin mutation or oncogenic KRAS activation (McConnell et al. [2009] Cancer Res.69:4125, Nandan et al. [2010] Molecular Cancer 9:63, respectively).KLF5 is regulated at the transcriptional, translational, and post-translational level.Previous studies indicate that the protein kinase GSK3β and E3 ubiquitin ligase FBW7 facilitate proteosomal degradation of KLF5 protein via phosphorylation (GSK3β) and recognition (FBW7) of a phosphodegron sequence surrounding Ser303 in human KLF5.A recent genomic analysis of colorectal cancer tissues identified a somatic mutation (P301S) in KLF5 within the phosphodegron sequence (Sjöblom et al. [2006] Science 314:268).Aim: To investigate the impact of P301S mutation on KLF5 protein stability.Methods: Plasmids containing human wildtype (WT) and mutant (S303A, P301S, P301A, and P301E) KLF5 under the control of the CMV promoter were transiently transfected into HEK293 cells.The effect of FBW7 on the stability of KLF5 produced from the various constructs was investigated by cycloheximide chase and Western blot analysis.Transcriptional activity of various KLF5 constructs was examined by luciferase reporter assay with Cyclin D1 and CDC2 reporter plasmids.Results: All four KLF5 mutants examined are more resistant to FBW7-mediated proteosomal degradation as compared to WT KLF5.Proteasome inhibition using MG132 resulted in the accumulation of WT KLF5 but had little impact on P301S KLF5 protein levels.Co-immunoprecipitation experiments show that, in contrast to WT KLF5, P301S and S303A KLF5 do not interact with FBW7.Concomitantly, the P301S KLF5 mutant displayed reduced levels of phosphorylation at Ser303 in comparison with WT KLF5.Furthermore, luciferase assays using Cyclin D1 and CDC2 promoter constructs demonstrate significantly elevated transcriptional activity of P301S KLF5 as compared to WT KLF5.Conclusion: Our data indicate that residue 301 of KLF5 is critical for proper recognition of the phosphodegron sequence.Furthermore, we show that the colon cancer-derived P301S mutation in KLF5 inhibits FBW7 recognition of the phosphodegron, yielding a degradation-resistant KLF5 protein, elevated protein levels, and enhanced KLF5 transcriptional activity.These results suggest that the P301S mutation in KLF5 is potentially oncogenic in colon cancer.

The Scffbw7 E3 Ubiquitin Ligase Complex Targets Klf5 For Ubiquitination And Degradation In A Phosphorylation Dependent Manner

Abstract 3155: the SCFFBW7 E3 Ubiquitin Ligase Targets Krüppel-like Factor 5 (KLF5) for Proteolysis in Breast Cancer

FBW7-mediated ubiquitination and degradation of KLF5.

The Fbw7 Tumor Suppressor Targets Klf5 For Ubiquitin-Mediated Degradation And Suppresses Breast Cell Proliferation

The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs

Proteasomal Degradation of the KLF5 Transcription Factor Through a Ubiquitin-Independent Pathway.

Human Kruppel-like Factor 5 Is a Target of the E3 Ubiquitin Ligase WWP1 for Proteolysis in Epithelial Cells

KLF5 Promotes Breast Cell Survival Partially Through Fibroblast Growth Factor-Binding Protein 1-Perk-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization.

FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation

SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.

Oestrogen Causes Degradation of KLF5 by Inducing the E3 Ubiquitin Ligase EFP in ER-positive Breast Cancer Cells

FBW7 Targets KLF10 for Ubiquitin-Dependent Degradation.

Abstract 4962: Discovery of Cancer-Specific E3 Ligase Ligands for Targeted Protein Degradation

Sa1681 Inhibition of the Prostaglandin EP1 Receptor Suppresses Colon Cancer Cell Invasion and Metastasis.

Targeting SCF E3 Ligases for Cancer Therapies

FBW7 Suppresses Cell Proliferation and G2/M Cell Cycle Transition Via Promoting Γ-Catenin K63-linked Ubiquitylation.

The Ubiquitin Ligase Scffbxw7 Alpha Promotes Gata3 Degradation

Regulation of KLF4 by Posttranslational Modification Circuitry in Endocrine Resistance.

Regulation of APC Cdh1 E3 Ligase Activity by the Fbw7/cyclin E Signaling Axis Contributes to the Tumor Suppressor Function of Fbw7

The SCF–FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage

SCF FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction